Tudor I. Oprea

Orcid: 0000-0002-6195-6976

According to our database1, Tudor I. Oprea authored at least 63 papers between 1996 and 2024.

Collaborative distances:

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

Online presence:

On csauthors.net:

Bibliography

2024
Correction: Exploring DrugCentral: from molecular structures to clinical effects.
J. Comput. Aided Mol. Des., December, 2024

2023
Exploring DrugCentral: from molecular structures to clinical effects.
J. Comput. Aided Mol. Des., December, 2023

Pharos 2023: an integrated resource for the understudied human proteome.
Nucleic Acids Res., January, 2023

DrugCentral 2023 extends human clinical data and integrates veterinary drugs.
Nucleic Acids Res., January, 2023

Artificial Intelligence for Drug Discovery: Are We There Yet?
CoRR, 2023

2022
A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.
J. Chem. Inf. Model., 2022

Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds.
J. Cheminformatics, 2022

Diseases 2.0: a weekly updated database of disease-gene associations from text mining and data integration.
Database J. Biol. Databases Curation, 2022

2021
COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
PLoS Comput. Biol., 2021

A machine learning platform to estimate anti-SARS-CoV-2 activities.
Nat. Mach. Intell., 2021

TCRD and Pharos 2021: mining the human proteome for disease biology.
Nucleic Acids Res., 2021

DrugCentral 2021 supports drug discovery and repositioning.
Nucleic Acids Res., 2021

InContext: curation of medical context for drug indications.
J. Biomed. Semant., 2021

TIGA: target illumination GWAS analytics.
Bioinform., 2021

2020
Off-Patent Drug Repositioning.
J. Chem. Inf. Model., 2020

SmartGraph: a network pharmacology investigation platform.
J. Cheminformatics, 2020

2019
DrugCentral 2018: an update.
Nucleic Acids Res., 2019

2018
Leaving us with fond memories, smiles, SMILES and, alas, tears: a tribute to David Weininger, 1952-2016.
J. Comput. Aided Mol. Des., 2018

Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical records.
Health Informatics J., 2018

2017
DrugCentral: online drug compendium.
Nucleic Acids Res., 2017

Pharos: Collating protein information to shed light on the druggable genome.
Nucleic Acids Res., 2017

Obituary: Toshio Fujita, QSAR pioneer.
J. Comput. Aided Mol. Des., 2017

Protein biomarker druggability profiling.
J. Biomed. Informatics, 2017

Formalizing drug indications on the road to therapeutic intent.
J. Am. Medical Informatics Assoc., 2017

Drug target ontology to classify and integrate drug discovery data.
J. Biomed. Semant., 2017

TIN-X: target importance and novelty explorer.
Bioinform., 2017

Learning reference-enriched approach towards large scale active ontology alignment and integration.
Proceedings of the 2017 IEEE International Conference on Bioinformatics and Biomedicine, 2017

The ontology reference model for visual selectivity analysis in drug-target interactions.
Proceedings of the 2017 IEEE International Conference on Bioinformatics and Biomedicine, 2017

2016
Erratum to: Impact of similarity threshold on the topology of molecular similarity networks and clustering outcomes.
J. Cheminformatics, 2016

Impact of similarity threshold on the topology of molecular similarity networks and clustering outcomes.
J. Cheminformatics, 2016

Badapple: promiscuity patterns from noisy evidence.
J. Cheminformatics, 2016

ChemProt-3.0: a global chemical biology diseases mapping.
Database J. Biol. Databases Curation, 2016

2015
Protein Drug Target Prioritization for Illumination.
Proceedings of the AMIA 2015, 2015

2014
Genomic dark matter, druggability and misunderstood targets.
Proceedings of the AMIA 2014, 2014

2013
ChemProt-2.0: visual navigation in a disease chemical biology database.
Nucleic Acids Res., 2013

Discovery of a Novel Selective PPARγ Ligand with Partial Agonist Binding Properties by Integrated <i>in Silico</i>/<i>in Vitro</i> Work Flow.
J. Chem. Inf. Model., 2013

A systems chemical biology study of malate synthase and isocitrate lyase inhibition in Mycobacterium tuberculosis during active and NRP growth.
Comput. Biol. Chem., 2013

The CARLSBAD Database: A Confederated Database of Chemical Bioactivities.
Database J. Biol. Databases Curation, 2013

2012
Of possible cheminformatics futures.
J. Comput. Aided Mol. Des., 2012

2011
ChemProt: a disease chemical biology database.
Nucleic Acids Res., 2011

2010
Model-Free Drug-Likeness from Fragments.
J. Chem. Inf. Model., 2010

iPHACE: integrative navigation in pharmacological space.
Bioinform., 2010

2008
Scaffold Topologies. 2. Analysis of Chemical Databases.
J. Chem. Inf. Model., 2008

Scaffold Topologies. 1. Exhaustive Enumeration up to Eight Rings.
J. Chem. Inf. Model., 2008

Quantifying the Relationships among Drug Classes.
J. Chem. Inf. Model., 2008

Efficient Calculation of Molecular Properties from Simulation Using Kernel Molecular Dynamics.
J. Chem. Inf. Model., 2008

Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?
J. Comput. Aided Mol. Des., 2008

2007
Ligand-Based Virtual Screening by Novelty Detection with Self-Organizing Maps.
J. Chem. Inf. Model., 2007

Lead-like, drug-like or "Pub-like": how different are they?
J. Comput. Aided Mol. Des., 2007

Virtual screening applications: a study of ligand-based methods and different structure representations in four different scenarios.
J. Comput. Aided Mol. Des., 2007

2005
MTD-PLS: A PLS Variant of the Minimal Topologic Difference Method. III. Mapping Interactions between Estradiol Derivatives and the Alpha Estrogenic Receptor.
J. Chem. Inf. Model., 2005

Rapid Evaluation of Synthetic and Molecular Complexity for in Silico Chemistry.
J. Chem. Inf. Model., 2005

Surrogate data - a secure way to share corporate data.
J. Comput. Aided Mol. Des., 2005

Descriptor collision and confusion: Toward the design of descriptors to mask chemical structures.
J. Comput. Aided Mol. Des., 2005

2004
An automated PLS search for biologically relevant QSAR descriptors.
J. Comput. Aided Mol. Des., 2004

2002
MTD-PLS: A PLS-Based Variant of the MTD Method, 2. Mapping Ligand-Receptor Interactions. Enzymatic Acetic Acid Esters Hydrolysis.
J. Chem. Inf. Comput. Sci., 2002

Distant collaboration in drug discovery: The LINK3D project.
J. Comput. Aided Mol. Des., 2002

Current trends in lead discovery: Are we looking for the appropriate properties?
J. Comput. Aided Mol. Des., 2002

2001
Is There a Difference between Leads and Drugs? A Historical Perspective.
J. Chem. Inf. Comput. Sci., 2001

2000
Property distribution of drug-related chemical databases.
J. Comput. Aided Mol. Des., 2000

1998
MTD-ADJ: A multiconformational minimal topologic difference for determining bioactive conformers using adjusted biological activities.
J. Comput. Aided Mol. Des., 1998

1997
A Different Method for Steric Field Evaluation in CoMFA Improves Model Robustness.
J. Chem. Inf. Comput. Sci., 1997

1996
Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors.
J. Comput. Aided Mol. Des., 1996


  Loading...